Tempest Therapeutics annual operating margin
2015
2016
2017
Tempest Therapeutics's operating margin was −28,585.08% for fiscal 2017.
View full Tempest Therapeutics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2017 | 2017-12-31 | −28,585.08% | −16178.96 pp |
| 2016 | 2016-12-31 | −12,406.13% | +13586.29 pp |
| 2015 | 2015-12-31 | −25,992.42% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2018 | 2018-09-30 | −14,192.73% | +2603.70 pp |
| Q2 2018 | 2018-06-30 | −6,155.56% | +15189.68 pp |
| Q1 2018 | 2018-03-31 | −6,549.25% | +16604.71 pp |
| Q4 2017 | 2017-12-31 | −46,090.22% | −27604.27 pp |
| Q3 2017 | 2017-09-30 | −16,796.43% | −7170.03 pp |
| Q2 2017 | 2017-06-30 | −21,345.24% | −11693.92 pp |
| Q1 2017 | 2017-03-31 | −23,153.97% | −8469.72 pp |
| Q4 2016 | 2016-12-31 | −18,485.95% | −5594.23 pp |
| Q3 2016 | 2016-09-30 | −9,626.40% | +14069.60 pp |
| Q2 2016 | 2016-06-30 | −9,651.32% | +47595.34 pp |
| Q1 2016 | 2016-03-31 | −14,684.25% | +97402.42 pp |
| Q4 2015 | 2015-12-31 | −12,891.72% | — |
| Q3 2015 | 2015-09-30 | −23,696.00% | — |
| Q2 2015 | 2015-06-30 | −57,246.67% | — |
| Q1 2015 | 2015-03-31 | −112,086.67% | — |
Across the available reported history, Tempest Therapeutics's operating margin decreased from −12,406.13% to −28,585.08%, a change of −16178.96 percentage points. The latest reported quarter, Q3 2018, shows −14,192.73%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tempest Therapeutics filings at SEC.gov ↗